ABSTRACT
In recent years, the number of patients diagnosed with prostate cancer has increased dramatically1,2, owing to the widespread use of prostate-specific antigen (PSA) testing and the possibility for cure of early disease. Standard treatments for prostate cancer are radical prostatectomy, external-beam radiotherapy, brachytherapy, hormonal therapy and observation. The choice of treatment depends on tumor staging, the patient’s age and comorbidity, and the urologist’s and patient’s preferences. A commonly ignored or not properly addressed aspect is the impact of prostate cancer therapy on the patient’s future sexual functioning3.
